Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?

Nature Clinical Practice Oncology volume 2, pages 134–135 (2005)Cite this article

boxed-textSpielberger R et al. (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351: 2590–2598

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4: 277–284

    Article  CAS  Google Scholar 

  2. Braun S et al. (2002) Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 22: 5492–5505

    Article  CAS  Google Scholar 

  3. Bao S et al. (2005) Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 288: L36–42

    Article  CAS  Google Scholar 

  4. Ellison CA et al. (2004) Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen. J Clin Immunol 24: 197–211

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Brigham and Women's Hospital,

    Stephen T Sonis

  2. Dana Farber Cancer Institute,

    Stephen T Sonis

  3. Harvard School of Dental Medicine, Boston, MA, USA

    Stephen T Sonis

Authors
  1. Stephen T Sonis
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Dr Sonis works as a consultant for Clinical Assistance Programs, which assisted in specific aspects of the study reviewed.

Glossary

WHO ORAL-TOXICITY SCALE

A five-grade system for measuring oral toxicity, produced by the World Health Organization

RTOG ACUTE RADIATION–MORBIDITY SCORING CRITERIA

A five-grade scale to rate damage to mucous membranes, produced by the Radiation Therapy Oncology Group

WCCNR REVISED STAGING SYSTEM

A four-grade scoring system to rate the severity of oral mucositis, produced by the Western Consortium for Cancer Nursing Research

FACT

Functional Assessment of Cancer Therapy

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sonis, S. Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?. Nat Rev Clin Oncol 2, 134–135 (2005). https://doi.org/10.1038/ncponc0104

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0104

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing